Evidence map›Paper›PMID 33030263›Full record

ArticleFEBS open bio2020

Cystatin C regulates the cytotoxicity of infection-induced endothelial-derived β-amyloid.

Ron Balczon, Kyle A Morrow, Silas Leavesley, Christopher M Francis, Trevor C Stevens, Ezinne Agwaramgbo, Christopher Williams, Reece P Stevens, Geri Langham, Sarah Voth and 3 more

Open access · goldAbstract read
In one paragraph

Article in FEBS open bio, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Lung endothelial cytopathic tau is sufficient to impair long-term potentiation during infection.American journal of respiratory cell and molecular biology · 2026
    Article
  2. Review
  3. American journal of physiology. Lung cellular and molecular physiology · 2024
    Article
  4. Review
  5. Gamma secretase activating protein promotes end-organ dysfunction after bacterial pneumonia.American journal of physiology. Lung cellular and molecular physiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Ron BalczonDepartment of Biochemistry and Molecular Biology, University of South Alabama, Mobile, AL, USA.ORCID 0000-0001-8263-7221
Kyle A MorrowDepartment of Cell Biology and Physiology, Edward Via College of Osteopathic Medicine, Monroe, LA, USA.
Silas LeavesleyCenter for Lung Biology, University of South Alabama, Mobile, AL, USA.ORCID 0000-0002-2684-9534
Christopher M FrancisCenter for Lung Biology, University of South Alabama, Mobile, AL, USA.
Trevor C StevensCenter for Lung Biology, University of South Alabama, Mobile, AL, USA.
Ezinne AgwaramgboDepartment of Physiology and Cell Biology, University of South Alabama, Mobile, AL, USA.
Christopher WilliamsIntensive Care and Pulmonology, Mayo Clinic, Eau Claire, WI, USA.
Reece P StevensCenter for Lung Biology, University of South Alabama, Mobile, AL, USA.
Geri LanghamDepartment of Physiology and Cell Biology, University of South Alabama, Mobile, AL, USA.
Sarah VothCenter for Lung Biology, University of South Alabama, Mobile, AL, USA.
Eugene A CioffiDepartment of Pharmacology, University of South Alabama, Mobile, AL, USA.
Susan E WeintraubDepartment of Biochemistry and Structural Biology and Mass Spectrometry Laboratory, University of Texas at San Antonio Health Sciences Center, TX, USA.
Troy StevensCenter for Lung Biology, University of South Alabama, Mobile, AL, USA.
University of South Alabama · USEdward Via College of Osteopathic Medicine · USMayo Clinic Health System · USThe University of Texas Health Science Center at San Antonio · US

Funding

T-type Calcium Channels and von Willebrand Factor ReleaseP01HL066299 · NHLBI · UNIVERSITY OF SOUTH ALABAMA · PI STEVENS, TROY · 2001 to 2022
$34.6M
Store-operated calcium entry: lung endothelial permeabilityR37HL060024 · NHLBI · UNIVERSITY OF SOUTH ALABAMA · PI STEVENS, TROY · 2010 to 2019
$3.9M
Store Operated Calcium Entry: Lung Endothelial PermeabilityR01HL060024 · NHLBI · UNIVERSITY OF SOUTH ALABAMA · PI STEVENS, TROY · 1998 to 2009
$3.0M
Lung Endothelial Aß in infectious proteinopathyR01HL148069 · NHLBI · UNIVERSITY OF SOUTH ALABAMA · PI STEVENS, TROY · 2020 to 2023
$1.5M
TRPC4-mediated calcium signals accelerate vascular remodeling in pulmonary arterial hypertensionK25HL136869 · NHLBI · UNIVERSITY OF SOUTH ALABAMA · PI FRANCIS, CHRISTOPHER MICHAEL · 2017 to 2021
$798k
CSR NIH HHS HL076125CSR NIH HHS HL135003CSR NIH HHS HL140182NHLBI NIH HHS K25 HL136869NHLBI NIH HHS P01 HL066299NHLBI NIH HHS R01 HL060024NHLBI NIH HHS R01 HL148069NHLBI NIH HHS R37 HL060024
6 · The paper itself

Abstract

Infection of rat pulmonary microvascular endothelial cells with the bacterium Pseudomonas aeruginosa induces the production and release of cytotoxic oligomeric tau and beta amyloid (Aβ). Here, we characterized these cytotoxic amyloids. Cytotoxic behavior and oligomeric tau were partially resistant to digestion with proteinase K, but cytotoxicity was abolished by various denaturants including phenol, diethylpyrocarbonate (DEPC), and 1,1,1,3,3,3-hexafluoro-2-isopropanol (HFIP). Ultracentrifugation for 8 h at 150 000 g was required to remove cytotoxic activity from the supernatant. Ultracentrifugation, DEPC treatment, and immunodepletion using antibodies against Aβ also demonstrated that cytoprotective protein(s) are released from endothelial cells during P. aeruginosa infection. Mass spectrometry of endothelial cell culture media following P. aeruginosa infection allowed identification of multiple potential secreted modulators of Aβ, including cystatin C, gelsolin, and ApoJ/clusterin. Immunodepletion, co-immunoprecipitation, and ultracentrifugation determined that the cytoprotective factor released during infection of endothelial cells by P. aeruginosa is cystatin C, which appears to be in a complex with Aβ. Cytoprotective cystatin C may provide a novel therapeutic avenue for protection against the long-term consequences of infection with P. aeruginosa.

Indexed as

Amino Acid SequenceAmyloid beta-PeptidesAnimalsCell DeathCystatin CCytoprotectionEndopeptidase KEndothelial CellsPseudomonas aeruginosaPseudomonas InfectionsRatsAmyloid beta-PeptidesCystatin CEndopeptidase KAβcystatin Cendothelial cellpneumoniaPseudomonas aeruginosaTau protein

Identifiers

PMID33030263
PMCPMC7609779
OpenAlexW3091954696

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.